Trial
NCT03224585
Treatment of Acute Pericarditis With Anakinra
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Virginia Commonwealth University
Collaborators
—
Condition
Acute Pericarditis
Intervention
Anakinra
Why stopped
Study was terminated because dramatic benefits seen during the first 24 hours of drug administration combined with COVID restrictions on research activities suggested it was both unethical and unnecessary to complete the planned enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-02-23